基于诊断编码的索赔用于识别支气管扩张症患者非结核分枝杆菌肺病的有效性。
Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients.
作者信息
Ku Jennifer H, Henkle Emily M, Carlson Kathleen F, Marino Miguel, Winthrop Kevin L
出版信息
Emerg Infect Dis. 2021 Mar;27(3):982-985. doi: 10.3201/eid2703.203124.
Abstract
Nontuberculous mycobacteria infection is increasing in incidence and can lead to chronic, debilitating pulmonary disease. We investigated the accuracy of diagnosis code-based nontuberculous mycobacteria lung disease claims among Medicare beneficiaries in the United States. We observed that these claims have moderate validity, but given their low sensitivity, incidence might be underestimated.
摘要
非结核分枝杆菌感染的发病率正在上升，并可导致慢性、使人衰弱的肺部疾病。我们调查了美国医疗保险受益人中基于诊断编码的非结核分枝杆菌肺病索赔的准确性。我们观察到这些索赔具有中等效度，但鉴于其低敏感性，发病率可能被低估。
Zotero 插件